Improvement of quality assistance to dual patients with personality disorders associated

INTRODUCTION: The coexistence in the same person of several mental illnesses, among them an addition (the so-called Dual Pathology) is a prevalent but underdiagnosed pathology with clinical characteristics, specific diagnoses and therapies. Patients who present Dual Pathology with an associated personality disorder constitute one of the cores of Severe Mental Disorder. Providing quality care to these patients is one of the challenges of the therapeutic teams. Otherwise, the worsening of the clinical evolution will complicate the treatment of both disorders.

OBJECTIVES: To evaluate the efficacy of treatment programs with long-acting injectable antipsychotics in dual patients with associated personality disorders, in the care networks of addictions of Galicia and northern Portugal

METHODOLOGY: This is a specific study on patients under treatment with long-acting injectable antipsychotics: open, observational, indication-prescription type and with a follow-up period of 12 months. We present the data of the pilot phase.

RESULTS: These specific patients present the most impaired profile: higher infection rate greater legal problems and unfavourable social parameters. The off-label use of these drugs, very scarce in the Portuguese network, represents about 40% of the cases in the Galician network of additions, mainly "aripiprazole ". "aripiprazole" is associated with high retention and abstinence rates: more than 70% remain in treatment and abstinent. There is, as well, a decrease of hospitalizations and emergency services.

CONCLUSIONS: These results demonstrate the efficacy of these intervention programs for dual patients with associated personality disorders.